|

dornase alfa i.v. and cisplatin Clinical Trials

1 actively recruiting trial

Pipeline

Phase 2: 1

Top Sponsors

  • National Cancer Institute, Slovakia1

Indications

  • Dornase Alfa1
  • Refractory Germ Cell Tumors1
  • Cancer1

Other1 trial

Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer.
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.